EBS Breaking Notice: Rosen, Trusted National Trial Counsel, Encourages Emergent BioSolutions Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - EBSNewsfile Corp • 05/29/21
Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Emergent BioSolutions Inc.PRNewsWire • 05/28/21
Emergent BioSolutions Poised To Receive FDA Nod to Restart J&J COVID-19 Shot Production at Baltimore Plant After Mishap: WSJBenzinga • 05/28/21
EBS INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.Newsfile Corp • 05/27/21
Emergent BioSolutions's Single-Dose Chikungunya Vaccine Candidate Effective Even After Two Years of VaccinationBenzinga • 05/26/21
Emergent BioSolutions Announces Positive Two-Year Persistence Data From Phase 2 Study Evaluating CHIKV VLP, the Company's Chikungunya Virus Virus-Like Particle Vaccine CandidateGlobeNewsWire • 05/26/21
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBSNewsfile Corp • 05/25/21
HAGENS BERMAN Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Now, Securities Fraud Class Action FiledNewsfile Corp • 05/24/21
Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Emergent BioSolutions Inc. of Securities Class Action LawsuitNewsfile Corp • 05/24/21
Emergent BioSolutions Stock News: Berger Montague Announces Investigation Into Securities Fraud Allegations Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021Newsfile Corp • 05/23/21
EBS Stock News: Berger Montague Investigates Alleged Securities Fraud Claims Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021Newsfile Corp • 05/22/21
EBS News: Berger Montague Investigates Securities Fraud Allegations Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021Newsfile Corp • 05/21/21
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.Newsfile Corp • 05/21/21
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Emergent BioSolutions Inc. (EBS)PRNewsWire • 05/20/21
EBS Breaking News: Rosen, Leading Trial Attorneys, Encourages Emergent BioSolutions Inc. Investors to Secure Counsel Before Important June 18 Deadline in Securities Class Action - EBSNewsfile Corp • 05/19/21
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Against Emergent BioSolutions Inc.Newsfile Corp • 05/19/21
Emergent CEO says FDA is holding over 100 million J&J Covid vaccine doses for further testing after botched dosesCNBC • 05/19/21
Emergent says J&J vaccine snafu caused by challenge of making two vaccines at scaleMarket Watch • 05/19/21
Emergent BioSolutions Stock Falls As Executives Face Questions As Part Of Botched Vaccine ProbeBenzinga • 05/19/21
LAWSUIT FILED: Emergent BioSolutions Inc. Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLPNewsfile Corp • 05/19/21
ROSEN, A TOP RANKED LAW FIRM, Encourages Emergent BioSolutions Inc. Investors to Secure Counsel Before Important June 18 Deadline in Securities Class Action - EBSPRNewsWire • 05/18/21
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 05/18/21
Emergent BioSolutions News: Berger Montague Investigates Potential Securities Fraud Claims Against Emergent BioSolutions Inc. (EBS); Lead Plaintiff Deadline is June 18, 2021Newsfile Corp • 05/18/21
Kessler Topaz Meltzer & Check, LLP Files A Shareholder Class Action Lawsuit Against Emergent Biosolutions Inc. (NYSE: EBS) For Violations Of Federal Securities Laws With Expanded Class PeriodPRNewsWire • 05/17/21
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 05/17/21
